Autor: christine.stump@joimax.com

joimax® celebrates its 10th anniversary presence with 900 users in China and reports a jump in Q1-2017 sales

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe, Germany – April 11th, 2017 – joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, just celebrated its 10 years’ birthday in China with an outstanding 3 days event in Chongqing. More than 900 surgeons out of 2,000 users in China only took part in live surgeries, workshops and a scientific program on endoscopic spinal technologies including MISS fusion techniques. Besides, joimax® organized the presentation of its latest systems like the TESSYS® ISeeU and iLESSYS® Delta in product trainings as well as newest tools for endoscopic treatment in an exhibition hall. The program was supported by joimax® Faculty Members from Europe, USA and other countries. In the course of the meeting a Chinese Faculty Team with 13 members was inaugurated by Wolfgang Ries, Founder and CEO of joimax® and Qin-Guang You, President of joimax® China. ”Due to the growing education and training needs in the Asian region the time has come to form a local team for this important market”, explains Wolfgang Ries. “It is a great honor to lead this team and to support the further growth of joimax®”, says the head of the Faculty Team, Prof. Yue Zhou from the Third Military Medical University in Chongqing. He was awarded with the joimax® Handshake Award in Gold for his exceptional commitment and the members of the group received the joimax® Handshake Award in Silver.

After very satisfying growing sales figures in 2016 (31 % growth vs. 2015), joimax® is proud to announce a jump in sales in the first quarter 2017. Consolidated figures show an increase of 60 % compared to the same period of last year. “This is a very encouraging development, showing the continuing expansion and growth of the group”, states Wolfgang Ries, Founder and CEO of joimax®.

joimax® obtains full product registration in Thailand, and is now active in 10 Asian countries

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe, Germany – February 27th, 2017 – joimax® further ensures its market access in Asia. The German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery is expanding its presence and recently has obtained full product registration from the Thai Food & Drug Administration (FDA). joimax® also has approvals in South Korea, China, Singapore, Indonesia, Hong Kong and Vietnam. For Malaysia, Taiwan and Japan, the certification for the product range is expected in 2017. “We are constantly pushing the registration process in Asia to extend the availability of joimax® products. Thus, joimax® is well prepared to further widen its market presence in Asia, demonstrating our commitment to the fastest growing region of the world,” states Wolfgang Ries, Founder and CEO of joimax®.

For years, joimax® has been working with the Korean Wooridul group, the world’s largest Specialized Spine Hospital Network. Starting in 2017, joimax®, together with the Wooridul Hospital in Seoul, will offer International courses for Minimally Invasive Spinal Surgery (MISS). In a series of four courses, provided in basic and advanced level, the education of international spine surgeons is ensured. The first one, chaired by joimax® faculty Dr. Sang-Ho Lee, South Korea, recently took place. The one-week training programs offer surgeons the opportunity to learn percutaneous endoscopic techniques and other minimally-invasive procedures with lectures, operation observation and hands-on-workshops. Since 2004, more than 600 spine surgeons and specialists from 41 countries have participated in these courses at Wooridul.

After the National Minimal Invasive Spinal Summit Forum, together with the 4th joimax® User Meeting in December, joimax® China, headquartered in Chengdu, will celebrate its 10th birthday in April 2017. On this occasion, numerous internationally well-known faculties will meet in Chongqing, China to share experience and expertise. Lectures and live surgeries are planned to be held in two hospitals and to be broadcasted via Internet.

Participants of the National Minimal Invasive Spinal Summit Forum & 4th joimax User Meeting, held in Zhenghou City, China from Dec. 23rd until 25th, 2016

joimax® shows again strong growth trend in 2016 and gets issued next new patents holding now more than 150 patents and trademarks worldwide

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe, Germany – January 17th, 2017 – the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery joimax® announces again very satisfying growing sales figures. Record sales in 2016 are representing another 31% growth vs. 2015. This is in line with a Compound Annual Growth Rate (CAGR) from 2007 – 2016 of around 32%. Projections into 2017 show even accelerated growth due to the worldwide increasing adoption rate of the joimax® procedures.

joimax® is active in 45 countries by now and meanwhile enjoys a strong reputation in Europe and also in Asia which will now spread out into the US-market as well. “The entry in force of the CPT 2017 reimbursement Codebook (Current Procedural Terminology) as of January 1st, 2017, is a milestone towards the full acceptance of endoscopic minimally invasive spine surgery techniques. The codebook now contains the first endoscopic spinal surgery code, under which the specific transforaminal (TESSYS®) and/or interlaminar (iLESSYS®) procedures marketed by joimax® are now eligible in the USA and this will further contribute to fully increase sales in the US as well” states Wolfgang Ries, Founder and CEO of joimax®.

joimax® technologies are based on worldwide intellectual property and the company holds now more than 150 patents and trademarks. Only in 2016 18 patents and patent publications were issued to joimax®. The latest one is Patent No. EP 2 983 622 for the EndoLIF® Cage, which has been introduced to offer a minimally invasive as well as open (TLIF) alternative for fusion in the lumbar spine as an optimal treatment option for surgeons.

The company is busy on inventing and innovating next minimally invasive systems with regards to newer implants based on the EndoLIF® technology but also decompression methods based on its endoscopic systems. This will now be completed with Intracs®, the new Interaoperative Navigation Tracking & Control System with which joimax® instruments can be navigated directly at the tip. The Intracs® Navigation and Monitor Unit is integrated in the joimax® Endoscopic Tower and all necessary tools are tailored for the TESSYS® (transforaminal) and iLESSYS® (interlaminar) procedures as well as for minimally invasive stabilization procedures, like EndoLIF® (Lumbar Interbody Fusion) and Percusys® (Percutaneous Screw-Rod Stabilization).

DWG 2016 in Hannover, Germany: joimax® shows major presence with daily lunch symposia and Meet the Expert Sessions at its booth

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe, Germany – December 8th, 2016 – from Dec 1st to 3rd, 2016 the most important German spine congress has taken place at the Hannover Congress Centre. joimax® as global acting German developer and marketer of technologies and training methods for endoscopic minimally invasive spinal surgery again exhibited at the 11th congress of the German Spine Society (DWG). The congress attracted an increasing number of attendees who gathered for the latest news on spinal surgery as well as to learn about the techniques and results of endoscopic spine surgery and the benefits of these techniques for both the surgeon and their patients.

dwg_2016joimax® presented its complete product range including the newly launched MultiZYTE® RT (e.g. for rhizotomy) as well as MultiZYTE® SI for Sacroiliac Joint therapy and the Intracs® Interaoperative Navigation Tracking & Control System. With Intracs®, a fully endoscopic integrated electromagnetic based system, the joimax® instruments can be navigated directly at the tip which allows tracking of instruments with a diameter in the 1mm range. In the course of the congress joimax® also held two well attended lunch symposia covering the whole scope of surgical indications and also the field of pain therapy up to decompression. Furthermore joimax® offered daily “Meet the Expert”-Sessions at its booth where spine surgeons were given the possibility to participate on the extensive experience of well-known German spine specialists.

From left to right: Dr. Menno Iprenburg, NL; Awardee Alastair Gibson, MD, Scotland; Dr. Ralf Wagner, Germany; Wolfgang Ries, Founder & CEO joimax® GmbH
From left to right: Dr. Menno Iprenburg, NL; Awardee Alastair Gibson, MD, Scotland; Dr. Ralf Wagner, Germany; Wolfgang Ries, Founder & CEO joimax® GmbH

“The endoscopic minimally invasive techniques are becoming more and more the first choice in spinal surgery. This is also reflected in the steadily and now fast growing number of studies showing the benefits on this treatment modalities”, says Wolfgang Ries, CEO and founder of joimax®. The most recent study by Alastair Gibson, MD from Edinburgh, Scotland called “A randomized controlled trial of TED vs Microdiscectomy” has recently been published online in the European Spine Journal.  During his long-time use of joimax® endoscopic systems and educational work Dr. Gibson published a huge number of studies on endoscopic minimally invasive spinal surgery. Lately in October 2016 joimax®, together with the Paracelsus Medical University (PMU), had the honor of conferring him with the Parviz Kambin Award for his excellence in endoscopic spinal surgery. This event took place during the CME-certified workshop course held at the PMU in Salzburg, Austria. The Award is presented to pioneers in the field of endoscopic minimally invasive spine surgery, to which group of Awardees Alastair Gibson was elected there.

COA 2016 in Beijing, China: joimax® shows major presence and inaugurates new NASS-joimax® MISS training centre

Veröffentlicht am von christine.stump@joimax.com

Irvine, CA and Karlsruhe, Germany – November 28th, 2016 – joimax®, the global acting German developer and marketer of technologies and training methods for endoscopic minimally invasive spinal surgery, again exhibited at Chinese Orthopedic Association (COA), which has taken place from Nov 17th to 20th, 2016 at China National Convention Center in Beijing, China. During the exhibition, the new NASS – joimax® MISS Training Centre has been inaugurated.

img_6512

The 18th Chinese Orthopedic Association Annual Meeting and the 11th International Congress of Chinese Orthopedic Association (COA) this year has again taken place in Beijing and was visited by around 35,000 surgeons gathering for the latest research results and up to date information on technology and clinical progression in orthopedics including Spine Surgery. joimax® had a major presence with a large booth showing its endoscopic minimally invasive product range. Furthermore on the two major meeting days 30 lectures of well-known experts were given at its booth.

From left to right: Edward Dohring, MD, NASS Board of Directors; Prof. Yue Zhou, Xinqiao Hospital, Chairman of Chinese Society for MISS and joimax® faculty; Jeffrey C. Wang, MD, NASS Board of Directors; Prof. Xiaoguang Liu, Vice President Peking University Third Hospital; Prof. Jie Qiao, President Peking University Third Hospital; Wolfgang Ries, CEO & founder joimax® GmbH; Brad Repsold, NASS Assoc. Executive Director; Michael Roberz, International Sales Director joimax® GmbH; Qinguang You, General Manager joimax® China.
From left to right: Edward Dohring, MD, NASS Board of Directors; Prof. Yue Zhou, Xinqiao Hospital, Chairman of Chinese Society for MISS and joimax® faculty; Jeffrey C. Wang, MD, NASS Board of Directors; Prof. Xiaoguang Liu, Vice President Peking University Third Hospital; Prof. Jie Qiao, President Peking University Third Hospital; Wolfgang Ries, CEO & founder joimax® GmbH; Brad Repsold, NASS Assoc. Executive Director; Michael Roberz, International Sales Director joimax® GmbH; Qinguang You, General Manager joimax® China.

During the COA the new NASS-joimax® MISS Training Centre in China has been inaugurated on Friday Nov. 18th, 2016. The ceremony has taken place at the joimax® booth together with leaders from the Peking University Third Hospital and members of the NASS Board of Directors. The Chinese market is a very important one for joimax®: Chinese surgeons are highly interested in adopting and deepening their knowledge in endoscopic minimally invasive techniques. joimax® is playing a major role in advanced training and is a driving power in the field of continuing education.

“With the launch of TESSYS® IseeUTM, which has been newly designed especially for the Chinese market, joimax® offers an even more simplified access under facilitated orientation”, says Wolfgang Ries, CEO and founder of joimax®. “The existing TESSYS® trays can furthermore be upgraded with the TESSYS® ISeeUTM supplements” he continues.

Moreover, joimax® also presented its latest product, the newly launched Intracs® Interaoperative Navigation Tracking & Control System for the first time in China.

FDA Clearance for joimax® Vaporflex® and Legato® electrosurgical probes

Veröffentlicht am von christine.stump@joimax.com

Irvine, CA and Karlsruhe, Germany – November 9th, 2016 – joimax®, the global acting German developer and marketer of technologies and training methods for endoscopic minimally-invasive spinal surgery, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Vaporflex® and Legato® electrosurgical probes with radiowave technology for open and endoscopic spine surgery.

Those joimax® Electrosurgical Instruments are comprised of a series of instruments to facilitate the delivery of electrical energy from an RF generator to the patient tissue for use in cutting and/or coagulation of tissue. All Vaporflex® and Legato® probes use radio frequency which is generated by high oscillating electrical current received from a commercially available RF generator.

The new Vaporflex® system is optimized for versatile use due to different lengths, diameters and probe tips to allow endoscopic transforaminal and interlaminar procedures. It is both compatible and cleared also for the use with all Endovapor®/SurgiMax® and SurgiMax® Plus electrosurgical units and enables an easy swap of the Triggerflex® to the new Vaporflex® system. The bipolar Vaporflex® probes can easily be adopted to the complete range of joimax® systems. joimax® offers all its probes in a kit containing a sterilization tray, the hand piece as well as a shaft and a connection cable.

Vaporflex Illustrations joimax®

The monopolar and bipolar Legato® probes which support the rhizotomy procedures with the existing Multiuse and both newly launched products MultiZYTE® RT for Facet Joint Denervation and MultiZYTE® SI for SI Joint Therapy.

“Both the Vaporflex® and Legato® probes are ready for several generations of radiofrequency generators” says Wolfgang Ries, CEO and founder of joimax®. “Spinal surgeons are now enabled to perform the range of joimax® procedures with even more flexibility and ergonomics in the USA as well. This way we further enhance surgical interventions in endoscopic minimally-invasive spinal surgery” he continues.

joimax® shows major presence at NASS 2016 with a User Meeting and Workshop at Harvard Medical School, a NASS CME Lab and an Expert Panel Forum at the exhibition booth

Veröffentlicht am von christine.stump@joimax.com

Irvine, CA and Karlsruhe, Germany – October 25, 2016 – joimax®, the global acting German developer and marketer of technologies and training methods for endoscopic minimally-invasive spinal surgery, will again exhibit at the annual meeting of the North American Spine Society (NASS) 2016, taking place from October 26 – 29 in Boston, USA. Prior to the convention, on Monday, October 24, joimax® will hold a User Meeting followed by a workshop at the Harvard Medical School Conference Center. On Tuesday, October 25, the NASS CME-Lab with a joimax® station will take place. During the exhibition a group of internationally respected spine experts will also give presentations in a forum at the joimax® booth.

Key topics of the joimax® User Meeting will be centered around the endoscopic treatment of degenerative spinal diseases on the basis of the joimax® portfolio products with TESSYS®, CESSYS®, iLESSYS® Delta systems as well as EndoLIF® and Percusys®. A group of spine experts will share their expertise and extensive knowledge on the treatment of spinal diseases. The meeting will be completed with a cadaver lab with 3-4 stations at the Conference Center of the Harvard Medical School to train attendees on the whole range of endoscopic minimally-invasive spine surgery applications based on the joimax® techniques.

Tuesday’s NASS CME-Lab will be chaired by Professor Michael Y. Wang, M.D. FACS, University of Miami Miller School of Medicine, Miami, Florida, another pioneering spine surgeon and joimax® faculty member, who recently published a special edition in the Journal of Neurosurgery called Neurosurgical Focus, focused on Endoscopic Spine Surgery.

Additionally, joimax® will host a “Meet the Expert Forum” with presentations at its booth given by Dr. Ralf Wagner and Dr. Erik Traupe, both from Germany, and also Dr. Menno Iprenburg from the Netherlands. Topics discussed will include the benefits of spinal endoscopic transforminal and interlaminar decompression methods over traditional ones. joimaxs’® novel treatment options for advanced indications enjoy a fast growing adoption rate of its endoscopic technologies worldwide will also be discussed.illu-multizyte-si-intracs-joimax_web

“In the context of the annual NASS meetings’ we aim to share the latest information, innovative techniques and best practices with renowned spine care professionals from around the world. These joimax® activities will satisfy the requirements of spine specialists to take advantage of the latest innovations and technologies in endoscopic minimally-invasive spine surgery,” says Wolfgang Ries, CEO and founder of joimax®.

“With our existing product range as well as with our newly launched products – the MultiZYTE® SI endoscopic sacroiliac joint therapy set, MultiZYTE® RT for endoscopic minimally-invasive treatment of the facet joint and the new Intracs® Intraoperative Navigation Tracking & Control System, joimax® uniquely enhances its endoscopic minimally-invasive product portfolio to fully meet users’ needs,” he continues.

Eurospine 2016: joimax® launches its new MultiZYTE® SI-Joint Endoscopic Therapy Set and its new Intracs® Intraoperative Navigation Tracking & Control System

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe – October 05, 2016 – joimax®, the global acting German developer and marketer of technologies and training methods for endoscopic minimally invasive spinal surgery, will again exhibit at Eurospine 2016 taking place from October 5 – 7 in Berlin. During the conference, joimax®will launch two new products – the MultiZYTE® SI Endoscopic Sacroiliac Joint Therapy Set and its new Intracs® Intraoperative Navigation Tracking & Control System.

multizyte-si-treatment

MultiZYTE® SI Endoscopic Sacroiliac Joint Therapy is developed for the treatment of the Sacroiliac Joint Syndrome (SIJS), which has been rediscovered as a major back pain generator in recent years. This kind of pain is commonly felt in the lower back, the gluteal region, the hip and thigh and can even radiate into the leg and foot. Until the 1930s, SI-Joint was the main reason for low back pain, but since 1934 the focus has been on disc herniation. According to recent studies 15 to 25% of all low back pain is caused by the SI-Joint and up to 43% in patients having undergone lumbosacral fusion. MultiZYTE® SI joimax® now offers a well developed and lasting treatment option for this disease.

joimax_broshure_intracs_fiagon_titel

joimax® Endoscopic Tower with Intracs® Navigation and Monitor Unit - not yet FDA cleared
joimax® Endoscopic Tower

The Intracs® Intraoperative Navigation Tracking & Control System was developed in cooperation between joimax® GmbH Karlsruhe and fiagon GmbH in Berlin, both located in Germany. With the Intracs® system, joimax® instruments can be navigated directly at the tip using Fiagons “chip at the tip” technology which allows tracking of instruments with a diameter in the 1mm range. The Intracs ® Navigation and Monitor Unit is integrated in the joimax® Endoscopic Tower and all necessary tools are tailored for the TESSYS® (transforaminal) and iLESSYS® (interlaminar) procedures as well as for minimally invasive stabilization procedures, like EndoLIF® and Percusys®. The main features of the Intracs® system are needle navigation through Vector-Tip-Target processing tools, the merging of 2D X-Rays with 3D- images of a patient’s CT or MRI scans, and the constant orientation control of any endoscope used in joimax procedures.

“With these two new developments we are in the position to enhance our endoscopic minimally-invasive product portfolio, driving adoption rates to meet new heights. With the world unique Intracs® system, navigation is now faster, safer and more accurate than ever before using an electromagnetic (EM) field. Radiation exposure for both, patients and surgeons will be significantly reduced,” says Wolfgang Ries, CEO and founder of joimax®. “Additionally the learning curve for all spinal endoscopic procedures offered by joimax® will now be significantly reduced and the rapid expansion of all these techniques is now well layed-out,” he continues.

JOIMAX® ANNOUNCES RELEASE OF FIRST ENDOSCOPIC AMA CPT CODE Company also releases newly designed joimax® homepage

Veröffentlicht am von christine.stump@joimax.com

Irvine, CA – September 26, 2016 – The AMA (American Medical Association) released the CPT 2017 Codebook (Current Procedural Terminology), now containing the first endoscopic spinal surgery code no. 62380. This new code covers endoscopic decompression of the spinal cord, nerve root(s), including laminotomy, partial facetectomy, foraminotomy, discectomy and/or excision of herniated intervertebral disc, 1 interspace, lumbar, and will be enforced as of January 1st, 2017. Under this code the specific transforaminal (TESSYS®) and/or interlaminar (iLESSYS®) procedures are fully covered in the USA herewith, which are already marketed by joimax® in 45 countries.

“The definition of this new code in the CPT codebook 2017 is a major milestone towards the acceptance of endoscopic minimally invasive spine surgery techniques and its benefits to both the surgeon and their patients,” states Wolfgang Ries, Founder and CEO of joimax®. Since 2012 joimax®  had been driving this effort to obtain CPT codes as these procedures required submission to payors for reimbursement coverage which was granted only in single cases under temporary codes, so-called T-codes.

“joimax® has been instrumental in driving the effort to obtain full code coverage of endoscopic spinal surgery,” says Daniel Laich, DO, Swedish Convenant Hospital, Chicago, who had been participating and presenting in almost every AMA meeting over the last five years. Due to the high research and publication activities by key users like Albert Telfeian, MD, PhD, at Rhode Island Hospital at Brown University, and a group of users around him, strong evidence has been accepted by AMA authorities, justifying the release of this new CPT code.

Many papers and publications on joimax® products can now be downloaded from the newly released joimax® homepage. The completely redesigned website offers visitors richer insight into the company’s innovative products and systems. A quick and easy access to essential information and features is available, including the latest workshop and education activities, which are essential in endoscopic minimally-invasive spinal surgery.

Meanwhile joimax® offers basic and advanced workshop training courses mainly in the USA, Germany and Austria, and oversees a participation population of almost 3,000 physicians. Independent training courses are also performed in China and Korea to support the fast growing Asian markets. Detailed information about those courses are updated regularly at www.joimax.com.

The website uses the latest technology so the site is compatible with today’s browsers and mobile devices, such as smartphones and tablets. Visitors can also use the new website to stay informed with the latest company news. The new website goes live today and is located at the same address: https://www.joimax.com.

joimax® STUDIES PUBLISHED IN WORLD NEUROSURGERY TESSYS® system proves to be surgical rescue solution for kyphoplasty complication and thoracic disc herniation.

Veröffentlicht am von christine.stump@joimax.com

Irvine, Germany, September 14th, 2016 – joimax®, the expert in endoscopic minimally invasive spine surgery, is pleased to announce another publication on its technologies to be released in World Neurosurgery (2016). In the paper called “Transpedicular Lumbar Endoscopic Surgery for Highly Migrated Disc Extrusions, a preliminary series and surgical technique,” published by Krzok G et al, 21 patients underwent this procedure with the TESSYS® system. The paper follows two technical notes by Wagner R et al in which he shows joimax® techniques as surgical rescue solutions in a kyphoplasty complication and another one for the treatment of a thoracic disc herniation, all published in World Neurosurgery.

The first technical note mentioned above describes the case of a 72-year-old woman with a leakage of the kyphoplasty cement into the spinal canal (a described and known complication), where the joimax® technology was successfully used as a rescue solution to remove the cement and decompress the nerval structures preventing major surgery. The second technical note describes the transforaminal endoscopic foraminoplasty and discectomy for the treatment of a thoracic disc herniation. A 31-year-old woman with severe thoracic back pain over one year was successfully treated by using the transforaminal endoscopic approach so that open surgery was not needed.

Over the years a growing number of studies show the outstanding advantages of endoscopic minimally invasive spinal surgery, such as the prospective Randomized Controlled Trial (RCT) of Ruetten et al in 178 patients and by Hoogland et al in a study of 262 consecutive cases of transforaminal endoscopic spinal surgery. Both were published in Spine 2008, Vol. 33, Issue 9. Another retrospective evaluation with 195 patients of Jasper et al (Clinical Neurology & Neurosurgery 2013, Vol. 115, Issue 10) and a multi-centric MIS prospective registry published by Sclafani et al (IJSS 2015, Vol. 9, Art. 69) with 86 patients, also showed very encouraging results. Beyond that, a special edition in the Journal of Neurosurgery called Neurosurgical Focus, published by Gokaslan Z, Telfeian A and Wang M focused on Endoscopic Spine Surgery was released in February 2016 (JNS 2016, Vol. 40, No. 2).

“Working with Endoscopic Spine Surgery for more than 12 years (her performed already 2,400 Tessys® procedures in daysurgery in analgo-sedation) and seeing its evolution is just amazing and I wonder where we will be in five or ten years from now”, says Menno Iprenburg, MD from Veenhuizen, NL, who continues to be involved in many of these studies.

Albert Telfeian, MD, PhD from Brown University, RI is very happy about the actual hit rate on PubMed when searching for endoscopic spinal surgery, “To date we’ve received a rate of 2,730 papers on http://www.ncbi.nlm.nih.gov/pubmed/?term=endoscopic+spinal+surgery and I am really excited how many indications are treatable with endoscopy already today,” said Telfeian.

“Shortly another RCT study will be published by Gibson et al demonstrating the quality and great success rate of endoscopic spine treatments with a high adoption rate, especially in Asian countries, and in some countries where there is more than 50% growth per annum”, says Wolfgang Ries, founder and CEO of joimax®.